WCG Unveils Strategic Alliance Program for CROs
WCG's suite of clinical trial solutions will be made available to a wider range of CROs.
WCG has launched a program to augment the existing capabilities of CROs and further support the work they do in driving innovation in clinical trials. By providing CROs with access to its clinical trial operations data, the WCG CRO Strategic Alliance Program enables CROs to better serve patients and research sponsors, and accelerate the pace at which new therapies are brought to market.
Read more about this new alliance program
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
Generative AI Transforms Clinical Study Report DevelopmentSeptember 16th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
